Clinical Trial Update: A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for lazertinib as a monotherapy or in combination with amivantamab in adults with advanced non-small cell lung cancer; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Amivantamab (amivantamab)
• Lazertinib (lazertinib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: ACTIVE_NOT_RECRUITING